Concepedia
Statistics
Publications
32
Citations
1.6K
Authors
1
Location
Oslo, Norway
Targovax (Norway) is a company institution in Oslo, Norway known for oncology, cancer immunotherapy, and immunology.
Top concepts
OncologyCancer ImmunotherapyImmunologyTumor ImmunologyCancer ImmunologyImmunotherapyCombination ImmunotherapyMedicineAntitumor Immune ActivationAdenovirus Vectors
Targovax (Norway), Norway
22 publications · 502 citations
10
h-index
1–1 of 1
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
Łukasz Kuryk, Anne‐Sophie W. Møller, Magnus Jäderberg · OncoImmunology · 2018 · 101 citations · Full text
Medicine, Immunology, Oncology +17
TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial
Daniel H. Palmer, Juan W. Valle, Yuk Ting et al. · British Journal of Cancer · 2020 · 67 citations · Full text
Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
Łukasz Kuryk, Anne‐Sophie W. Møller, Magnus Jäderberg · Journal of Medical Virology · 2019 · 53 citations · Full text
Life Sciences, Immunology, Oncology +17
Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein‐2 cell entry receptor
Łukasz Kuryk, Anne‐Sophie W. Møller · Journal of Medical Virology · 2020 · 47 citations · Full text
Medicine, Immunology, Oncology +15
Antitumor‐specific T‐cell responses induced by oncolytic adenovirus ONCOS‐102 (AdV5/3‐D24‐GM‐CSF) in peritoneal mesothelioma mouse model
Łukasz Kuryk, Anne‐Sophie W. Møller, Mariangela Garofalo et al. · Journal of Medical Virology · 2018 · 42 citations · Full text
1–5 of 32